SYSTEMIC EVALUATION AND GOOD PRACTICE OF THE SURGICAL PATIENT IN TREATMENT WITH ANTICOAGULANTS OR ANTIAGGREGANTS: NARRATIVE REVIEW

I. Catalano^1*§, A. Annicchiarico², C. Annicchiarico^1§ and A. Coppola³

¹ Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy;
² University of Bari “A. Moro”, Bari, Italy;
³ Independent Researcher, Naples, Italy.

*Correspondence to:
Irene Catalano,
Department of Clinical and Experimental Medicine,
University of Foggia,
71122 Foggia, Italy.
e-mail: irecata@icluod.com

§ Equal contribution

Received: 03 March, 2025 Accepted: 30 April, 2025

ISSN 2975-044X (online) ISSN 2038-4106 (print) Copyright © by BIOLIFE 2025 This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. Disclosure: All authors report no conflicts of interest relevant to this article.

ABSTRACT

Objective: The aim of the following scientific research is to evaluate the management of patients in anticoagulant and antiaggregant therapy during dental surgical procedures, and at the same time assess and analyze the risk of thrombosis or bleeding depending on whether the drug is discontinued or not. Methods: It is carried out a research and analysis of systemic reviews in the English language that were about the application of artificial intelligence in dental fields, using databases such as Web of Science, Scopus, PubMed, using keywords “oral surgery” ,”anticoagulants and oral surgery”. Results: Patients on anticoagulant or antiaggregant therapy can undergo dental surgery without stopping the medication, provided local measures are taken to control bleeding. Discontinuation of therapy is not recommended due to the risk of thromboembolic events, especially with warfarin and antiaggregants. The new oral anticoagulants (NAO) require only a possible dose adjustment in high-risk cases. Risk assessment through the ASA classification and type of procedure is crucial for safe management. Conclusions: The dental management of patients on anticoagulant or antiaggregant therapy requires a balance between hemorrhagic risk and thromboembolic risk. Discontinuation of therapy is not recommended; local measures to control bleeding are better and specialists should be consulted if necessary.

KEYWORDS: Oral health, anticoagulant, blood, oral surgery, dental management